These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine. Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N. Acta Med Iugosl; 1987 Dec; 41(5):363-72. PubMed ID: 3128058 [No Abstract] [Full Text] [Related]
7. IgM nephropathy associated with penicillamine. Rehan A, Johnson K. Am J Nephrol; 1986 Oct; 6(1):71-4. PubMed ID: 3963062 [Abstract] [Full Text] [Related]
8. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Bacon PA, Tribe CR, Mackenzie JC, Verrier-Jones J, Cumming RH, Amer B. Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658 [Abstract] [Full Text] [Related]
9. Hypothesis for the pathogenesis of sodium aurothiomalate (Myocrisin) induced immune complex nephritis. Skrifvars B. Scand J Rheumatol; 1979 Oct; 8(2):113-8. PubMed ID: 156394 [Abstract] [Full Text] [Related]
10. Proteinuria in rheumatoid arthritis--drug-induced or amyloid? Bourke BE, Woodrow DF, Scott JT. Ann Rheum Dis; 1981 Jun; 40(3):240-4. PubMed ID: 6787994 [Abstract] [Full Text] [Related]
13. [Conspicuous accumulation of membranous glomerulonephritis following gold therapy in chronic polyarthritis--a side effect of a new preparation?]. Burger HR, Briner J, Spycher MA. Schweiz Med Wochenschr; 1979 Mar 24; 109(12):423-31. PubMed ID: 106466 [Abstract] [Full Text] [Related]